Alert: Due to routine maintenance on the OSHA website, some pages may be temporarily unavailable.
To report an emergency, file a complaint with OSHA or ask a safety and health question, call 1-800-321-6742 (OSHA).
|1||2012 - 07/13/2012 - Applicability of the Bloodborne Pathogens standard during transection of the umbilical cord.|
|2||2008 - 11/24/2008 - OSHA's position on the use of Novartis' Fluvirin® device.|
|3||2007 - 03/02/2007 - Requirements for safety-engineered sharps for stockpiled pandemic influenza vaccines and pre-filled syringes.|
|4||2004 - 09/01/2004 - Limiting factors for implementing the use of engineering controls, i.e., safety scalpels, under the Bloodborne Pathogens standard.|
|5||2004 - 05/27/2004 - Bloodborne Pathogens Standard application to bifurcated needles; acceptability and appropriateness of safety bifurcated needles.|
|6||2004 - 04/20/2004 - Clarification from OSHA regarding the use of the NeedleguardTM in a hospital environment.|
|7||2003 - 03/19/2003 - Engineering control requirements for allergy and immunization injections.|
|8||2003 - 02/20/2003 - Needlestick Safety and Prevention Act and the requirement to include safety-engineered sharps devices in pre-packaged surgical kits or trays.|
|9||2002 - 11/21/2002 - Safer medical devices must be selected based on employee feedback and device effectiveness, not Group Purchasing Organizations.|
The Department of Labor does not endorse, takes no responsibility for, and exercises no control over the linked organization or its views, or contents, nor does it vouch for the accuracy or accessibility of the information contained on the destination server. The Department of Labor also cannot authorize the use of copyrighted materials contained in linked Web sites. Users must request such authorization from the sponsor of the linked Web site. Thank you for visiting our site. Please click the button below to continue.